European Journal of Inflammation,
Journal Year:
2024,
Volume and Issue:
22
Published: Jan. 1, 2024
The
safety
of
vancomycin
in
children
requires
special
attention.
evidence
from
active
pharmacovigilance
systems
about
vancomycin-related
adverse
drug
reactions
(ADRs)
was
rare.
We
aimed
to
investigate
the
association
between
doses
and
ADRs
among
children.
This
retrospective
cohort
study
included
a
total
643
inpatient
Children
who
received
were
regarded
as
exposed
groups
classified
into
low-dose,
normal-dose,
high-dose
groups.
Those
did
not
receive
had
similar
severity
infection
unexposed
group.
ADR
signal
detection
performed
by
China
Hospital
Pharmacovigilance
System.
Logistic
regression
analyses
conducted
explore
effect
intravenous
on
ADRs.
156
patients
(178
cases)
group
487
(364
top
three
reported
eosinophilia
(
n
=
75,
48.1%),
hemoglobin
decreased
72,
46.2%),
blood
bilirubin
increased
13,
8.3%)
Patients
showed
higher
risk
when
compared
with
those
group,
fully
adjusted
ORs
(95%
CIs)
6.91
(3.61,
13.20),
7.80
(3.87,
15.76),
8.80
(4.08,
19.01),
respectively.
Besides,
normal-dose
show
significantly
increased,
It
is
important
monitor
eosinophilia,
decreased,
pediatrics
receiving
vancomycin,
especially
vancomycin.
Clinics and Practice,
Journal Year:
2025,
Volume and Issue:
15(1), P. 14 - 14
Published: Jan. 6, 2025
This
study
analyzes
urinary
tract
infections
(UTIs)
in
a
hospital
Central
Portugal
over
five-year
period,
focusing
on
bacterial
prevalence,
patient
demographics,
and
antibiotic
resistance
patterns.
investigation
aims
to
provide
insights
that
can
guide
improved
infection
control
treatment
strategies.
A
total
of
6161
positive
urine
cultures
collected
five
years
were
examined,
with
particular
emphasis
2019
due
peak
rates.
The
analysis
explored
demographic
factors
such
as
sex
clinical
service
origin,
resistance.
Special
attention
was
given
hospitalized
patients,
especially
those
undergoing
invasive
procedures,
their
increased
vulnerability
infection.
found
UTIs
more
prevalent
female
reflecting
anatomical
susceptibilities.
Hospitalized
individuals,
particularly
requiring
at
greater
risk.
predominant
bacteria
Escherichia
coli,
Klebsiella
pneumoniae,
Enterococcus
faecalis,
differences
prevalence
by
origin.
Resistance
Imipenem
E.
coli
increased,
raising
concerns
about
last-resort
treatments.
However,
other
antibiotics
declined,
suggesting
improvements
recent
stewardship
measures.
During
the
COVID-19
pandemic,
overall
consumption
decreased
changes
practices.
findings
highlight
importance
strict
control,
targeted
prevention
measures,
rational
use
combat
Ongoing
surveillance
personalized
approaches
are
essential
improve
UTI
management
outcomes.
Antibiotics,
Journal Year:
2025,
Volume and Issue:
14(2), P. 141 - 141
Published: Feb. 1, 2025
Carbapenemase-producing
Enterobacterales
(CPE)
represent
an
important
threat
to
global
health,
resulting
in
urgent
issue
clinical
settings.
CPE
often
exhibit
a
multidrug-resistant
(MDR)
phenotype,
thus
reducing
the
antimicrobial
armamentarium,
with
few
antibiotics
retaining
residual
activity
against
these
pathogens.
Carbapenemases
are
divided
into
three
classes
(A,
B,
and
D)
according
Ambler
classification
system.
Among
these,
KPC
(class
A),
NDM,
VIM,
IMP
B),
OXA-48-like
most
carbapenemases
terms
of
diffusion
impact.
has
been
observed
worldwide,
current
endemicity
multiple
territories
around
world.
In
this
context,
clonal
spread
plasmid-mediated
transmission
have
contributed
worldwide
among
different
species.
recent
years,
novel
molecules
showing
excellent
vitro
vivo
developed
CPE.
However,
emergence
traits
resistance
already
reported
several
cases,
mitigating
initial
promising
results.
This
review
aims
provide
updated
description
major
carbapenemases,
their
distribution,
future
perspectives
limit
CPEs.
Molecules,
Journal Year:
2025,
Volume and Issue:
30(3), P. 585 - 585
Published: Jan. 27, 2025
Artemisia
argyi
volatile
oil
(AAVO)
is
a
kind
of
natural
with
abundant
active
components
and
remarkable
medicinal
healthcare
value.
However,
AAVO
has
low
solubility,
stability,
bioavailability.
Here,
to
address
these
issues,
nanoemulsion
system
(AAVO-Ne)
constructed
using
phase
transition
titration,
the
conditions
are
continuously
optimized
combine
it
chitosan,
forming
chitosan
composite
(AAVO-NeCs).
The
structure
was
analyzed
Fourier
transform
infrared
(FT-IR)
spectroscopy,
performance
evaluated
through
in
vitro
antibacterial
tests,
release
experiments,
antioxidant
assays.
results
indicated
that
typical
characteristic
absorption
peaks
shifted
AAVO-Ne
spectrum
new
appeared
AAVO-NeCs,
which
implied
formation
AAVO-NeCs
involved
not
only
physical
encapsulation
process
but
also
certain
chemical
interactions,
thus
enhancing
stability
bioactivity
composites.
Compared
AAVO,
exhibited
1.87-fold
increase
activity
against
antibiotic-resistant
bacteria.
Meanwhile,
study
demonstrated
biphasic
pattern.
showed
significant
enhancement
activity.
Overall,
demonstrate
improved
solubility
efficacy
as
well
high-efficiency
delivery,
antibacterial,
sustained-release,
properties.
These
attributes
position
promising
candidate
for
applications
drug
food
preservation,
other
fields,
offering
innovative
solutions
contributing
sustainable
development
related
industries.
Science Progress,
Journal Year:
2025,
Volume and Issue:
108(1)
Published: Jan. 1, 2025
Objective
The
aim
of
this
study
is
to
establish
a
population
pharmacokinetic
(PK)
model
for
patients
undergoing
continuous
veno-venous
hemodiafiltration
(CVVHDF)
and
optimize
the
dosing
regimen
colistin
sulfate.
Methods
A
prospective
observational
in
single
center
was
conducted
on
who
were
administrated
with
sulfate
CVVHDF
at
least
48
h.
Blood
samples
obtained
prior
four
six
blood
(primarily
C
0.5h
,
1h
2h
4h
6h
)
after
dosing.
concentration
determined
by
ultra-high
performance
liquid
chromatography-tandem
mass
spectrometry
assay.
NONMEM
program
used
PK
perform
Monte
Carlo
simulations.
predictability
stability
internally
evaluated
goodness
fit
plots,
visual
prediction
check,
bootstraps.
Results
total
86
plasma
concentrations
from
20
modeling.
two-compartment
first-order
linear
elimination
best
described
characteristics
Cystatin
(CysC)
body
weight
(WT)
identified
as
covariates
clearance
(CL).
Internal
evaluation
results
showed
that
final
had
good
performance.
simulations
only
when
WT
50
kg
CysC
≥3.07
mg/l,
65
=
5.11
minimum
inhibitory
(MIC)
0.25
target
attainment
probability
(PTA)
daily
dose
1.5
million
U
≥90%.
All
treatment
regimens
fail
achieve
PTA
MIC
1
mg/l.
Conclusions
With
decrease
levels
increase
WT,
may
need
be
increased.
It
prudent
consider
an
initial
doubling
subsequent
maintenance
200–225
unit
daily,
administered
2–3
divided
doses,
attain
standard.
This
registered
Chinese
Clinical
Trial
Registry
(
www.chictr.org.cn
(trial
registration
number
ChiCTR2300072191).
The
emergence
of
carbapenem-resistant
Escherichia
coli
(CREC)
poses
crucial
challenges
in
clinical
management,
requiring
continuous
monitoring
to
inform
control
and
treatment
strategies.
This
study
aimed
investigate
the
genomic
epidemiological
characteristics
CREC
isolates
obtained
from
a
tertiary
hospital
China
between
2015
2022.
Next-generation
sequencing
was
used
for
profiling,
data
patients
were
integrated
into
analysis.
ST405
(21.2%),
ST167
(20.3%)
ST410
(15.9%)
most
prevalent
30
distinct
sequence
types
(STs)
identified
among
113
unique
isolates.
Infections
caused
by
clone
severe
underlying
diseases
associated
with
higher
in-hospital
mortality
rates,
particularly
aged
≥65
years.
Furthermore,
exhibited
greater
number
virulence
resistance
genes
than
non-ST405
clones.
gene
eaeX
mph(E)
msr(E)
exclusively
found
clones,
while
other
(agn43,
ipad
malX)
(armA,
catB3
arr-3)
more
this
Additionally,
showed
minimum
inhibitory
concentrations
both
meropenem
imipenem
superior
growth
under
challenge.
Galleria
mellonella
assays
revealed
that
virulent
predominant
STs.
Our
findings
underscore
threat
posed
clone,
which
exhibits
enhanced
extensive
drug
resistance.
These
results
highlight
urgent
need
stringent
surveillance
targeted
interventions
curb
its
further
dissemination
prevent
potential
outbreaks.
Frontiers in Surgery,
Journal Year:
2025,
Volume and Issue:
12
Published: March 13, 2025
Objective
The
objective
of
this
study
was
to
preliminarily
examine
the
demographic
profiles,
spectrum
pathogenic
bacteria,
and
antibiotic
resistance
patterns
among
patients
with
periprosthetic
joint
infection
(PJI),
while
also
offering
deeper
insights
into
microbiological
characteristics
specifically
in
diabetic
PJI.
Methods
A
retrospective
analysis
278
diagnosed
PJI
from
January
2019
December
2024
at
our
institution
performed.
Demographic
patients,
distribution
data
on
were
statistically
analyzed
employing
chi-square
test
t
-test.
Results
Gram-positive
cocci
comprised
56.6%
all
whereas
coagulase-negative
staphylococci
constituted
28.1%
total.
Throughout
period,
a
significant
decrease
observed
proportion
rifampicin-resistant
(CoNS),
27.0%
10.4%.
Similarly,
marked
decline
noted
gentamicin-resistant
Staphylococcus
aureus,
50.0%
15.4%.
Conversely,
there
dramatic
increase
amoxicillin-clavulanate-resistant
gram-negative
bacilli,
23.1%
64.7%.
incidence
fungal
infections
notably
higher
compared
their
non-diabetic
counterparts.
Conclusion
This
demonstrates
that
pattern
bacteria
profiles
undergoes
continuous
variation.
Moreover,
exist
differences
between
those
diabetes
without
patients.
serves
as
crucial
theoretical
foundation
empirical
support
for
rigorous
tailored
development
anti-infective
treatment
strategies
various
types
mSystems,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 16, 2025
ABSTRACT
Hypervirulent
Klebsiella
pneumoniae
(hvKp)
strains
are
increasingly
recognized
for
their
aggressive
nature,
which
leads
to
severe
clinical
outcomes.
The
emergence
of
multidrug-resistant
constitutes
a
substantial
challenge
management.
Phage
therapy
offers
potential
solution
the
antibiotic
resistance
crisis.
A
hvKp
strain,
K2420
(K20
serotype),
was
used
isolate
bacteriophages
from
hospital
sewage.
morphology,
biological
properties,
and
genome
characteristics
were
analyzed
using
transmission
electron
microscopy,
plaque
assays,
whole-genome
sequencing.
Therapeutic
safety
efficacy
assessed
in
an
acute
pneumonia
murine
model
induced
by
intratracheal
injection
K2420.
Assessment
parameters
included
bacterial
load,
phage
titer,
body
temperature,
cytokine
levels,
histopathological
findings,
other
relevant
indicators.
PK2420,
member
Autographiviridae
family
Przondovirus
genus,
identified.
It
rapidly
lyses
K.
inhibits
biofilm
formation,
exhibits
burst
size
37.4
plaque-forming
units/cell.
is
stable
at
temperatures
ranging
0°C
40°C
pH
values
between
6
9.
Its
genome,
41,155
bp
length,
contains
46
coding
sequences.
has
no
genes
associated
with
resistance,
virulence,
or
lysogeny.
In
vivo
,
PK2420
substantially
reduced
loads,
improved
survival
rates,
alleviated
severity
without
observable
side
effects.
lytic
activity
against
both
vitro
models,
providing
promising
safe
option
treatment
infections.
IMPORTANCE
Our
investigation
provides
insights
into
interaction
mechanism
among
hypervirulent
phage,
host
mouse
model,
offering
valuable
reference
future
research
on
pharmacokinetics.
This
study
demonstrated
that
bacteriophage
biosafety
therapeutic
hvKp-induced
pulmonary
infections
dissemination
model.
These
findings
suggest
may
be